-
Life Sciences & Healthcare newsletter, June 2024
This month’s Life Sciences & Healthcare newsletter bring you a short overview of how off-label use of medicinal products is regulated in the Baltics. This is especially interesting in the light of the recent judgement of the European Court of Justice on off-label use of medicinal products. Risk-benefit balance includes risks resulting from off-label use The […]
-
Life Sciences & Healthcare newsletter, April 2024
This month’s Life Sciences & Healthcare newsletter focuses on the distance selling of medicinal products. In February, the Court of Justice of the European Union made a fundamental decision concerning the legality of distance selling of over-the-counter (OTC) medicinal products. At the same time, in all of the Baltic States the possibilities under the brand […]